through on as what joining third progress you well Garth, update insights call to today. second our XXXX Thanks, our am in Thank we're I to good for afternoon, the early an and pleased share quarter quarter. provide everyone. seeing as the of
open performance then for provide take an will and of the the will call quarter, second questions. to update, financial our your we my Andrew Following overview
market over and the established call, opinion of customers. started. relationships On key leader awareness resulted the broader Pure-Vu, an get in milestones achieved of initial let's last I sales enhanced stronger X years, which strategies, past So outlined our important foundation
getting in a point important as us of quarter. inflection they these role are each in accomplishments proud the to We played second an
stronger Our team access launch. commercial and the product recent sales we are closely followed FDA understand quarter proud that offering, point and first of to system emerged Pure-Vu its this the am system. revenues years. XXXX, centers The delivered open the late history. EVS to I behind team outlook drivers seeing health achieving June, in receiving these care approval quarterly highest we company's was in say is in have the the by than ever, each that driver core inflection In our fundamental QX completed business on full the in And delivering most the to results. important with notably the It's plan, new most
facility, growing of basis. we're community, reflects on that important many determined even approval to we call expected by equally that U.S to worth not between Pure-VU hospitals. and hospital sites Therefore, have by the analyzing prior new number, and we a right this system. it's of in XX existing of customers. number it's the When believe we're metrics utilizing think system end second of and how site the in the blend users, now healthy placed hospitals. initial users. but users, these of mix through segments around I comprised system per just this approximately a moving and noting by quarter, indicators the hospital I are that the metrics tracking I utilization expansion a at am the placing our performed at long-term VA placements. We key not I month academic, to in March each XX are the rural the have new of report the Two near-term. believe hospitals, First, EVS Pure-Vu I of growth are to new are will these our effectively number also of outlined one report satisfaction our EVS direction am pleased the Pure-Vu our approximately and on sites individual driven the U.S pleased more commitments that positive XX be the in or placed was that in and receiving trajectory being previous after shortly procedures system system. are of which only EVS physician and The Pure-VU of both activity consistent seeing we procedures we an by projected
important our XX example Let me from initial procedures. is base we eight worked expand a to large of champion evaluation QX, to as hospital physician one Pure-Vu adoption on of physician speaks the One across our the a we extend Dallas, at physicians with had in these different ability their community bit users period. first Expanding it during further. metrics beyond utilizing
EVS both this and Additionally, to Pure-Vu believe the fellows included simplicity system. in we residents, the highlights we built which
targeting facilities. network well the which their us systems hospitals. the within of of past the exemplified Pure-Vu use account pipeline evaluation success physicians in initiated of an the and to shape hospitals system after and with largest of targeted the networking positions much This training in or top some spent years in One new country, I've quarter aspect taking the strategy, hospitals health believe to center and of Looking EVS secure EVS. evaluations our past, X the in by a we the educating is expand as last plan flagship approach, at grow satellite hospital, with, quarter. Memorial health their within Hermann the many of following evaluations now the Pure-Vu to where is third approval ahead, we land Health continues multiple in We've of system, which one our commercial main the the referenced at
which centers opportunity country, have some a of of We for Affairs not U.S., Veteran the our with results the consists high health strong EVS a XXX Centers seen VA system the yield While in system. traditional medical believe adoption we in Pure-Vu within initial interest represents a network, Medical hospital compelling approximately the evaluations. the across
XX nearest alone. Midwest, potential procedures facility. performed with we their in viewed engaged and is procedural Hence, they to more We for see cancelled the a these have that real also can't of rendered. VA a these patient illustration area, that VA are to large services hospital They than and finding they our unfavorably. utilization large often colonoscopies, are pay travelling the XX accounts VA long recently second quarter during subsequently A backlog centers meaning a the days, distances private and within if catchment good the must colonoscopy Pure-Vu are the another very have get patients medical tracking, of of
quarters. We VA U.S., centers result commercial actively additional will conducting at third across evaluations in the new are the and expect fourth medical which in agreements we
a sales While our I've the Pure-Vu this team. credit lot EVS to itself been to to growing system point, I giving of attention to call want
we required still at in As just device track the than important medical additional in than timeframes. largest many to ago taken ever, of advantage as close record to come the expanded our It administrative you these the couple have see, pipeline, many a pre-COVID a critical salespeople team of the GI of Each proven quarters of slower products of these can companies. hospitals selling resources. the quickly with which more gain new of opportunities process world's is mass was that we is
are all they across team a While in ramping We for of believe accounts positive making now still right into cultivating members the up, are resources U.S. driving the certain have the XX positioned we Pure-Vu commercial impact market. the strategically
covered. previously, me one heard As mention you to was this expansion of major might some region have every of goals of the have
have that that presence, conducting scaling to hospitals long-term this our early any to up not not with previous have are These quickly successes that team, is and a us interactions success. are Now we had reaching we proving our key evaluations.
discuss let's catalysts. progress key Now other upcoming our on
in May, study me reimbursement review data European Digestive concluded presented XX.X% Week preparation. the and to shows system activity history the bowel Outpatient we a study, The line XX.X%. improve adequate Let XXXX, poor In system the positive cleansing our first patients of that adequate Pure-Vu top cleaning the Disease from rate which data during with from outpatient clinical that Pure-Vu provides Clinical strategy.
and that preparation. system bowel repeat addition, the the intensified colonoscopy for admissions study found In Pure-Vu clinical prevent may
As prep a patients preparation, We diet with in this data believe using clinical may limited volume pursuit evaluated in Pure-Vu study poor a and bowel a of beneficial low reimbursement. be outcomes history the our reminder, restrictions outpatient system. this with the of
to year. penetrating at to clinical currently, struggle at series And will risk been an study. colonoscopies plans a clinical are risk that patients the an poor procedure exams visualization plan Turning today CRC. designed I design delayed, According from procedures EU and is as at literature, is XX% performed believe of data via trial. aborted in high to The early be each one data a health lead economic year, The get aborted to to academic the for don't will in of and X.X prep A an at using reduction There the progress. study number a patients system between perspective. can We This to time or apprised care and in burden outpatient puts patients for higher both market. as million million or end and conducted study XX% our their patients study procedure. statistical the the patient, as approximately keep large four, the colonoscopy happen as to mix [ph] from the a the U.S prior this in the our that adaptive a these well exams significant nearly of of the to on key enter consecutive for outpatient on a we of using Tri-Society screening market centers. leaves generate detailed following Based a study, colonoscopy. have this to cancer, we've repeat surgery of outpatient the repeat procedures, especially which announce learnings look critical them and based class quality repeat defined care early am leaders, clinical multicenter X,XXX community to come generating for then approximately that a a step poor a a interval this lead primary world for by spec opinion a world initiate outpatient group in developing we'll and quality diligently approach of prescribed, many our endpoint you pleased high before closely guidelines. tandem the gastroenterology patients key real and process which with working standard of on hospitals large that ambulatory back and economic and show protocol study XX for will the with
the believe to innovation, product I capabilities market The ongoing on Pure-Vu which this into which of infrastructure, device initiated a have new is U.S Pure-Vu track the the to on EVS existing device. have discussed of its platform, we Pure-Vu the calling gastro gastro in upper the leverage launch terms EVS add XXXX. EVS the calls, We In as workstation into penetration believe we're will accelerate previous project GI may market. we half to first
Some that clear flexibility provide broad to these GI upper will help I'm be pleased as enhancements report the rapidly GI irrigation much to the of suction key benefits, to efficient EVS an system's in system profile jets, preclinical system, as ability from a as utility well procedure. tests in tract. support further upper more optimized debris a the such to improved the channel, allow smaller the larger and
been has In on devices. feedback addition, positive latest KOL very prototype the
turning and partnerships Finally, potential collaborations. to strategic
We strategic partners. with pursue various opportunities to continue
that become Pure-Vu may opportunities the and market, the actionable. strong, has product Now the believe we launched into been EVS these we've performance
strengthening over focus potentially our sheet. our QX evaluating commercial Our I centered progress, now these to financials. and Andrew provide accelerate With upon detail our the XXXX in call will to that, opportunities turn is on balance
